Gill Capital Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-15
Closed -$5.38K – 638
2026
Q2
$5.38K Hold
15
– – ﹤0.01% 502
2026
Q1
$3.76K Buy
+15
New +$3.73K ﹤0.01% 515

Other funds holding WST

Gill Capital Partners's WST Position: Q3 2026 in Review

Gill Capital Partners sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 15 shares — an estimated $5.38K sold.

Gill Capital Partners first reported a position in WST in Q1 2026 and held it in 2 quarters. The position peaked at $5.38K in Q2 2026. 878 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Gill Capital Partners reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Gill Capital Partners sold 15 West Pharmaceutical shares in Q3 2026, an estimated $5.38K.
  • Gill Capital Partners first reported a position in West Pharmaceutical in Q1 2026 and held it in 2 quarters.
  • Gill Capital Partners's West Pharmaceutical position peaked at $5.38K in Q2 2026.
  • 878 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Gill Capital Partners's 13F filing for Q3 2026, filed 13 Oct 2026.